Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma
Jinlu Liu,1,* Ling Yang,1,* Xin Yuan,2,* Meimei Xiong,1 Jiao Zhu,1 Wenbi Wu,1 Min Ren,1 Jianlin Long,3 Xuewen Xu,2 Maling Gou1 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, People’s Republic of China; 2Departm...
Guardado en:
Autores principales: | Liu J, Yang L, Yuan X, Xiong M, Zhu J, Wu W, Ren M, Long J, Xu X, Gou M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/045ef5ace9b046958b5b73304fca37bf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeted nanoparticle-mediated LHPP for melanoma treatment
por: Zhang Q, et al.
Publicado: (2019) -
Current Landscape and Open Questions on Adjuvant Therapies in Melanoma
por: Vincenzo De Falco, et al.
Publicado: (2021) -
Aptamer Hybrid Nanocomplexes as Targeting Components for Antibiotic/Gene Delivery Systems and Diagnostics: A Review
por: Rabiee N, et al.
Publicado: (2020) -
Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor
por: Sui M, et al.
Publicado: (2021) -
Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies
por: Arwa Alkaraki, et al.
Publicado: (2021)